 |
|
|
| |
Drug Interactions with Direct Acting Antiviral Combination of Paritaprevir/Ritonavir + Ombitasvir
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, May 26-28, 2015, Washington, DC, USA
Prajakta Badri1, Sandeep Dutta1, Haoyu Wang1, Thomas Podsadecki1, Akshanth Polepally1, Eoin Coakley2, Amit Khatri1, Jiuhong Zha1, Yi-Lin Chiu1, Walid Awni1, Rajeev Menon1 1AbbVie Inc., North Chicago, Illinois, United States; 2Former AbbVie employee
Clinical Pharm of HIV & Hepatitis Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir: Drug Interactions with Antiretroviral Agents - (06/01/15)
Clinical Pharm of HIV & Hepatitis Assessment of Drug-Drug Interactions Between Daclatasvir and Darunavir/Ritonavir or Lopinavir/Ritonavir - (06/03/15)
|
| |
|
|
|
|
|
